Search

Your search keyword '"Emer M Brady"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Emer M Brady" Remove constraint Author: "Emer M Brady" Topic type 2 diabetes Remove constraint Topic: type 2 diabetes
38 results on '"Emer M Brady"'

Search Results

1. Impact of the Remission of Type 2 Diabetes on Cardiovascular Structure and Function, Exercise Capacity and Risk Profile: A Propensity Matched Analysis

2. Energy intake and weight during the <scp>COVID</scp> ‐19 lockdown were not altered in a sample of older adults with type 2 diabetes in <scp>England</scp>

Catalog

Books, media, physical & digital resources

3. A cost comparison of an enhanced primary care diabetes service and standard care

4. Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials

5. Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point Trial

6. Relative protein intake and associations with markers of physical function in those with type 2 diabetes

7. Author response for 'Energy intake and weight during the COVID ‐19 lockdown were not altered in a sample of older adults with type 2 diabetes in England'

8. Lifestyle intervention improves Left atrial strain in type 2 diabetes: results from the DIASTOLIC randomised trial

9. EXTending availability of self-management structured EducatioN programmes for people with type 2 Diabetes in low-to-middle income countries (EXTEND)—a feasibility study in Mozambique and Malawi

10. Self-Compassion, Metabolic Control and Health Status in Individuals with Type 2 Diabetes: A UK Observational Study

11. Sleep extension and metabolic health in male overweight/obese short sleepers: A randomised controlled trial

12. A comparison of liver fat fraction measurement on MRI at 3T and 1.5T

13. 56-OR: Fibro-inflammatory Plasma Biomarkers and Relation to Cardiovascular Remodeling in Type 2 Diabetes (T2D)

14. Chronotype and well-being in adults with established type 2 diabetes: A cross-sectional study

15. Sex and ethnic differences in the cardiovascular complications of type 2 diabetes

16. The impact of COVID‐19 restrictions on accelerometer‐assessed physical activity and sleep in individuals with type 2 diabetes

17. Clinical associations with stage B heart failure in adults with type 2 diabetes

18. Cardiovascular determinants of exercise capacity in people with type 2 diabetes

19. Cardiovascular determinants of aerobic exercise capacity in adults with type 2 diabetes

20. Device-measured physical activity and its association with physical function in adults with type 2 diabetes mellitus

21. A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes

22. Rationale and design of a cross-sectional study to investigate and describe the chronotype of patients with type 2 diabetes and the effect on glycaemic control: the CODEC study

23. Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training tO Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study)

24. Guidelines for managing diabetes in Ramadan

25. Evaluation of a Family-Based Interactive Lifestyle Intervention to Reduce the Risk of Developing Type 2 Diabetes in the Future (PRE-STARt Intervention)

26. Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis

27. The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women

28. Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study)

29. Walking and inflammatory markers in individuals screened for type 2 diabetes

30. Assessment of response rates and yields for Two opportunistic Tools for Early detection of Non-diabetic hyperglycaemia and Diabetes (ATTEND). A randomised controlled trial and cost-effectiveness analysis

31. The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis

32. A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial

33. Effect of physical activity measurement type on the association between walking activity and glucose regulation in a high-risk population recruited from primary care

34. Sex differences and determinants of coronary microvascular function in asymptomatic adults with type 2 diabetes

35. The potential blunting effect of metformin and/or statin therapy on physical activity‐induced associations with HbA1c in type 2 diabetes

36. Association between subclinical right ventricular alterations and aerobic exercise capacity in type 2 diabetes

37. Association of ambulatory blood pressure with coronary microvascular and cardiac dysfunction in asymptomatic type 2 diabetes

38. Interrelationship between micronutrients and cardiovascular structure and function in type 2 diabetes